文献速递生殖医学

严重男性因素不育中胚胎植入前非整倍体遗传学检测的应用

Preimplantation genetic testing for aneuploidy in severe male factor infertility.
PubMed 文献 · Reprod Biomed Online · 2020-06-27

本回顾性队列研究纳入266例严重男性因素不育病例,比较行与未行PGT-A的囊胚移植结局。PGT-A组与非PGT-A组活产率分别为55.6%和51.1%(OR 1.19,95%CI 0.71-1.98,P=0.495),PGT-A并非活产的独立影响因素(aOR 1.33,95%CI 0.66-2.70,P=0.421),女性高龄是唯一与活产独立相关的因素(aOR 0.46,95%CI 0.22-0.96,P=0.041)。

要点

  • PGT-A组与非PGT-A组活产率分别为55.6%与51.1%,差异无统计学意义(OR 1.19,95%CI 0.71-1.98,P=0.495)。
  • PGT-A并非活产的独立影响因素(aOR 1.33,95%CI 0.66-2.70,P=0.421)。
  • 女性高龄是唯一与活产独立相关的因素(aOR 0.46,95%CI 0.22-0.96,P=0.041)。

核心结论

  • 在严重男性因素不育夫妇中,PGT-A似乎并非与每移植周期活产独立相关的因素。

研究设计与样本

  • 本回顾性队列研究纳入266例严重男性因素不育病例,其中PGT-A组90例、非PGT-A组176例。
  • 纳入标准为严重男性因素不育(无精子症及精子计数<1百万/ml)、女性年龄25-39岁、单囊胚冻融移植及无宫腔病变。
  • 主要结局为活产率(妊娠24周后活产),次要结局为着床率与临床妊娠率。

主要发现

  • PGT-A组与非PGT-A组活产率分别为55.6%与51.1%(OR 1.19,95%CI 0.71-1.98,P=0.495)。
  • PGT-A组与非PGT-A组着床率分别为65.6%与64.2%(OR 1.06,95%CI 0.62-1.80,P=0.827)。
  • PGT-A组与非PGT-A组临床妊娠率分别为62.2%与58.0%(OR 1.19,95%CI 0.71-2.01,P=0.502)。
  • PGT-A并非活产的独立影响因素(aOR 1.33,95%CI 0.66-2.70,P=0.421)。
  • 女性高龄是唯一与活产独立相关的因素(aOR 0.46,95%CI 0.22-0.96,P=0.041)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does the use of preimplantation genetic testing for aneuploidies (PGT-A) improve outcomes in couples with severe male factor infertility (SMFI)? DESIGN: This retrospective cohort study included SMFI cases that underwent blastocyst transfer with/without PGT-A. Inclusion criteria were SMFI (azoospermia and sperm count <1 million/ml), women aged 25-39 years, single vitrified-warmed blastocyst transfer, and no intracavitary pathologies. Patients were divided into PGT-A and non-PGT-A groups. The primary outcome was live birth rate (live birth of an infant after 24 weeks of gestation); secondary outcomes were implantation and clinical pregnancy rates. RESULTS: The study included 266 SMFI cases (90 and 176 in the PGT-A and non-PGT-A groups, respectively). Men and women in the PGT-A group were significantly older than those in the non-PGT-A group. The groups did not differ in terms of male factor categories, sperm collection methods or additional female factors. Live birth rates in the PGT-A and non-PGT-A groups were 55.6% and 51.1%, respectively (odds ratio [OR] 1.19, 95% confidence interval [CI] 0.71-1.98, P = 0.495). The implantation rates were 65.6% and 64.2%, respectively (OR 1.06, 95% CI 0.62-1.80, P = 0.827). The clinical pregnancy rates were 62.2% and 58.0%, respectively (OR 1.19, 95% CI 0.71-2.01, P = 0.502). The use of PGT-A was not an independent factor for live birth (aOR 1.33, 95% CI 0.66-2.70, P = 0.421). Advanced age in women was the only independent factor associated with live birth (aOR 0.46, 95% CI 0.22-0.96, P = 0.041). CONCLUSIONS: The use of PGT-A does not seem to be an independent factor associated with live birth per transfer in couples with SMFI.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Asoglu MR, Celik C, Serefoglu EC, et al. Preimplantation genetic testing for aneuploidy in severe male factor infertility. Reprod Biomed Online. 2020. PMID: 32763130. doi:10.1016/j.rbmo.2020.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。